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Sporulation of Bacilli is a developmental process that provides long-term 
viability in unfavorable environments.  Recently, biogenesis of extracellular vesicles 
(EVs) from Bacilli has also been reported to participate in various physiological and 
pathogenic phenomena. In this study, EVs were isolated from vegetative and 
sporulating Bacillus subtilis cells and characterized using mass spectrometry (MS)-
based proteomics, microscopy, and fluorescence spectrophotometry. The microscopic 
approach demonstrated that both vegetative and sporulating cells produce EVs. In the 
proteomic analysis, 156 proteins were identified with statistical significance in EVs 
 
 
collected at the vegetative phase and 185 proteins in EVs shed during sporulation. The 
two EV cargos showed qualitatively and quantitatively different proteome patterns. 
Sporulation-associated proteins had greater abundances in EVs at the sporulation stage. 
Additionally, a fusion-like event of EVs with B. subtilis cells was observed by a 
fluorescence de-quenching assay. Based on these observations, B. subtilis EVs are 
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Chapter 1:  Introduction 
1.1  Bacterial EVs  
1.1.1  General characteristics of bacterial extracellular vesicles 
(EVs) 
EVs are membranous and spherical vesicles shed by various eukaryotic and 
prokaryotic organisms.1,2 They are enclosed by a lipid bilayer with nano-scaled 
diameters of 20 – 2000 nm depending on the organism and are released to the 
extracellular region.3 The phenomenon of EV biogenesis is highly conserved across 
diverse organisms, suggesting that the EV production must have significant roles in 
life. Bacterial EVs were first observed from cultures of the Gram-negative bacterium 
Escherichia coli in the 1960s.4 Thereafter, studies using diverse biochemical 
techniques have progressed extensively in both Gram-negative and Gram-positive 
bacteria. Gram-negative bacterial EVs (also known as outer membrane vesicles, 
OMVs) have been validly reported with a range from 20 to 300 nm in diameter from 
various species.5 More recently, EVs were also found from some species of Gram-
positive bacteria with similar size distributions (Figure 1).6,7 As in the case with EVs 
of eukaryotes, bacterial EVs carry a number of cellular components, including proteins, 




compounds in a concentrated and protected form.8–10 Biological functions of EVs have 
also been discussed based on the components identified. 
 
1.1.2  Functions of bacterial EVs  
Bacterial EVs have been suggested to function in numerous physiological 
processes and pathogenesis in host cells (in case of pathogens).1,9 First of all, EVs play 
significant roles in bacterial intercellular communication and bacterium – host cell 
interactions as a novel secretion / delivery system for the biologically active 
components. The EV-mediated system has distinct advantages over other secretion 
pathways.5 EVs allow components unfavorable for secretion, such as membranous 
proteins, bacterial lipids and hydrophobic molecules, to be efficiently secreted to the 
extracellular region. For instance, P. aueruginosa EVs have been observed to 
incorporate hydrophobic pseudomonas quinolone signal (PQS), which controls quorum 
sensing.11,12 Mashburn and Whitely found that elimination of EVs significantly 
interrupts the cellular communication within a population and PQS-mediated group 
Figure 1. EVs isolated from Bacillus subtilis cells. Isolation method is described in 




activities.11  Another benefit is that soluble proteins in EVs can be protected from 
extracellular hydrolytic enzymes.5 Moreover, EVs deliver the functional components 
to distal sites in a highly concentrated form and enable targeted delivery using EV 
surface ligand - host receptor interactions.5,13  
Secondly, EVs may contribute to bacterial survival. EVs may package intrinsic 
and extrinsic damaging factors and implement their release.14 Accumulation of 
misfolded proteins and other toxic materials could attack bacterial cell surface and 
threaten their survival. EVs may rapidly remove these threatening components. For 
instance, a hypervesiculating E.coli mutant has been observed to have greater viability 
relative to a normal strain under surface-attacking conditions with either external or 
internal stress-inducers.14 From this observation, McBroom and Kuehn proposed that 
efficient removal of misfolded proteins is a key feature of the stress response pathway 
of EVs. They also suggested that the levels of EV formation and EV contents are 
affected by environmental stressors.14 Another proposed way by which EVs support 
bacterial survival is nutrient acquisition using receptors.5,12 For example, PQS carried 
by EVs functions not only in the intercellular communication but also in acquiring 
nutrients.12 PQS actively binds iron (Fe3+), which is crucial for bacterial survival. EVs 
are proposed to catch iron in the extracellular environment by forming PQS-Fe3+ 
complex and deliver it to parental cells by fusion or release near the cells.12 EVs can 
also enhance cell competitiveness by attacking other bacteria. Proteases and other lytic 
enzymes have been shown to be enveloped in EVs with active bacteriolytic activities.15 
Within EVs, these enzymes would degrade cell surfaces of either Gram-positive or - 




involvement in nucleation, communication and stabilization of biofilms.17,18 EVs have 
been observed to be shed from both Gram-positive and -negative bacterial biofilms.6,17  
In the case of pathogenic bacteria, EVs may play a role in their pathogenicity to 
host cells. EVs contain toxins and other virulent factors in biologically active forms.19–
21 These toxic materials can be delivered to host cells effectively through various 
mechanisms, including membrane fusion, bacterial adhesion-host receptor interaction, 
and endocytic uptake.22 EV production can be up-regulated in infected host cells, 
resulting in increase of virulence and activation of immune responses.5 The 
immunomodulatory functions of EVs will be further discussed in the topic of 
therapeutic applications. In addition to the direct functions, it can be assumed that EVs 
indirectly support pathogenic functions of bacteria by contributing to intercellular 
communication and bacterial survival as discussed above.  
The functions reviewed here are mostly based on studies of Gram-negative EVs. 
Gram-positive EVs are expected to have functional similarities because of comparable 
components identified in Gram-negative and Gram-positive EVs. 
1.1.3  Shedding mechanisms of bacterial EVs  
It is important to study the mechanisms of bacterial EV biogenesis in order to 
understand their functions and relevant biological processes. Several mechanisms have 
been proposed for Gram-negative bacterial OMVs, but most studies have considered 
disruption of interactions between outer membrane (OM) and peptidoglycan (PG) 
layers to be a key factor.1 In general, OM and PG are stably bridged through OM-PG 
linking proteins and OM-PG-IM (inner membrane) linking proteins. According to the 




proteins.1,5 Another likely mechanism of OMV biogenesis is contributed by proteins 
gathering at specific regions of the OM inner surface.5 Enrichment of periplasmic 
proteins would generate pressure outward, resulting in the budding of OMV. This 
model also requires removal of the OM-PG linkage. More recently, 
lipopolysaccharides (LPS) have been reported to significantly participate in OMV 
budding.1 LPS molecules (also known as endotoxins) are critical for the architecture of 
the Gram-negative bacterial cell surface and trigger immune responses in host 
organisms. Interaction of LPS with environmental stimulants could cause the bulging 
of OM. Gentamicin is a popular stimulant, which is known to interact with specific 
LPS species on the OM based upon charge attractions.23,24 This interaction would pull 
on the region of the OM containing the LPS species and modify the membrane 
curvature, inducing OMV release.25 The cell envelope structure of Gram-positive 
bacteria is substantially different from that of Gram-negative bacteria. The Gram-
positive bacterial cell has a single layer of membrane, which is covered by a thick layer 
of peptidoglycan.  Due to the structural difference, shedding mechanisms of Gram-
positive bacterial EVs are expected to be unlike those of Gram-negative bacteria. 
Further analysis of the mechanisms for both types of bacterial EVs are needed. 
1.1.4  Potential of EVs in therapeutic applications 
As discussed in the previous section, EVs may carry virulent factors and activate 
immunity in host cells.22 Furthermore, they have shown high efficiencies of 
internalization into host cells and are susceptible to biochemical manipulations 
including genetic recombination of parental cells.22,26,27 With these characteristics, EVs 




Clinical trials of immunization using bacterial EVs are rapidly emerging and some 
natural Gram-negative bacterial EVs have already been licensed as vaccine 
platforms.28–30 The attempt to develop vaccines using EVs initially started for 
serogroup B meningococcal disease induced by Gram-negative bacterium Neisseria 
meningitidis. The natural EVs from N. meningitidis have been successfully applied for 
epidemic control in Cuba, Norway, Chile, Brazil and New Zealand.30 Until now, the 
protein-based EV-vaccines are the only formulations that provide sufficient 
immunogenicity against the serogroup B meningococcal disease.30 In addition to the 
native forms, EVs have been genetically or physically modified in order to increase 
their efficacy for immunization and facilitate administration.26,27 During production 
and purification steps, the properties of EVs can be chemically and physically altered 
by mechanical shearing, and treatments with detergents or other chemicals.27 
Detergent-assisted EV extraction is the most popular treatment and known to produce 
higher yields with reduced toxicity from LPS. Considering these benefits, the 
detergent-treatment is considered to be necessary for EV-vaccines against the 
serogroup B meningococcal disease. However, this approach has also been found to 
decrease immunogenicity and promote aggregation.26 In order to overcome these side-
effects, genetic manipulations designed for toxicity attenuation and for increase of the 
EV yield have been implemented without detergent treatment.26 Further, diverse 
techniques to induce and enhance shedding of EVs have been employed, including 
induction of autolysis, inhibition of protein synthesis, and treatment with gentamycin.27 




is in progress, however development for Gram-positive bacterial infections has not 
started yet. 
1.1.5  Gram-positive bacterial EVs 
Originally, Gram-positive bacteria were considered not to shed EVs, since they 
lack outer membranes, but in 1990 EVs were observed microscopically from Gram-
positive bacteria.31 Subsequently, Gram-positive bacterial EVs from Staphylococcus 
aureus, B. anthracis, B. subtilis, Streptomyces coelicolor, Listeria monocytogenes, 
Clostridium perfringens, and Streptococcus pneumoniae have been isolated and 
characterized.6,7,21,32–35 Proteomic profiling of Gram-positive bacterial EVs was 
initially reported by Lee et al. for S. aureus.7 The proteome of EVs shed by S. aureus 
was found to contain proteins with similar functional annotations to those of OMVs 
from Gram-negative bacteria, including proteins involved in immunity, pathogenesis, 
and drug response.7,32,34 EVs of B. anthracis were reported to carry toxin components 
and, more importantly, be capable of immunization.21 In the study of B.subtilis, EVs 
were shown to be shed directly from cells, not from lipid aggregations and be disrupted 
by lipopeptide surfactin.6 
Characterization of EVs from Gram-positive bacteria is still at an early stage, 
while Gram-negative bacterial EVs have already been evaluated for antibiotic or 
vaccine development. Further investigation of the biogenesis mechanisms and 
biological activities of Gram-positive bacterial EVs are required for therapeutic 




1.2  Sporulation of Bacilli 
1.2.1  Gram-positive bacteria Bacilli 
The genus Bacilli are aerobic (or anaerobic under some conditions), rod-shaped 
and endospore-forming Gram-positive bacteria, which are widely found in soil and 
water. This genus was initially defined by Ferdinand Cohn in the 1870s.36 The Bacillus 
cell is typically composed of cytoplasm (including nucleoid and ribosomes), cell 
membrane, cell wall and flagella (Figure 2). Based on taxonomic criteria, Bacillus has 
been considered as the most heterogeneous genus with more than 80 solidly described 
species.37 In spite of the heterogeneity, Bacilli can be characterized by their 
morphology and simple biochemical analysis, such as test of color photomicrographs,38 
chromatographic analysis of fatty acid methyl esters,39 and 16S rDNA sequencing 
assay.40 The two important aspects of the genus Bacillus are endospore formation and 




pathogenic components (restricted to some species). The most familiar pathogenic 
species is B. anthracis, which carries three exotoxin components named: protective 
antigen, edema factor, and lethal factor.42,43 B. anthracis can deliver the toxins with 
high stability by forming spores, and thus the spores have been utilized for bioterrorism.  
Bacillus subtilis is the most extensively analyzed species among Bacilli. It was 
initially named Vibrio subtilis by Christian Gottfried Ehrenberg and renamed Bacillus 
subtilis by Cohn.36 Since then, several hundred B. subtilis strains have been found.41 
This species is readily found in soil and has been observed in normal gut commensal in 
human.44 A single cell of B. subtilis has numerous flagella, which provide efficient 
swarming mobility in liquids.45 Since it is highly amenable to genetic manipulation, B. 
subtilis is the most widely investigated Gram-positive bacterium and has served as a 
paradigm for various biochemical studies of bacteria, especially for analysis of 
sporulation.46 It seems appropriate to examine EVs shed by B. subtilis to establish basic 




1.2.2  Morphological differentiation of the sporulation stages 
Sporulation is a cell developmental process of Gram-positive bacteria that are 
responding to nutrition exhaustion. This distinct process has been regarded as a simple 
model of cellular differentiation.47 The formation of the endospore was first observed 
in B. subtilis and B. anthracis.41 The spore is structurally composed of spore core, 
membranes, cortex, spore coats, and (in some species) exosporium (Figure 3).48 The 
series of sporulation stages is typically classified based on distinct morphological 
changes (Figure 4).49 First, cells at the sporulation stage 0 are ordinarily growing under 
vegetative condition. Stage I designates the point at which a single axial chromatin 
filament is formed, while the cell at stage II produces an asymmetric septum at a pole 
of the cell. Stage II is often considered as the actual starting point of sporulation. As 
the asymmetric septum is completed, the smaller compartment, called a forespore, is 
engulfed by the larger compartment, termed a mother cell, which is a transition from 
stage II to stage III. Next, at stage III, the forespore becomes a free protoplast with two 




Outer coat Forespore 
Figure 3. Thin-sectioned TEM images of (A) B. subtilis spore (scale bar : 100 nm) and 




wall and cortex surround the forespore, followed by stage V in which spore coat 
proteins accumulate on the outer surface of the endospore. Eventually, the spore 
matures during stage VI and the mother cell lyses and releases the free spore in stage 
VII. The released spore becomes dormant and survive for a long time and under harsh 
conditions. They also can proceed to germination and reform vegetative cells under 
suitable environments.  
1.2.3  Distinct biochemical events occur during sporulation 
A number of biochemical events specific to sporulation have been analyzed and 
used to characterize sporulation stages. These events have distinct correlations with the 
morphological stages and result in synthesis of stage-specific proteins and other 
products.  In the early stages 0-II of sporulation, the cells increase production of diverse 
enzymes including α-amylase, proteases, and nucleases. Alkaline phosphatase and 
extracellular deoxyribonuclease are known as stage II markers.50 During the 
subsequent stages, other components important for spore maturation and their viability 
are expressed either in the forespore, in the mother cell, or at the interface between the 
mother cell and the forespore.49 Specifically at stage III, β -galactosidase and glucose 
dehydrogenase are highly enriched and thus they have been used for the stage screening 
as marker proteins characteristic of stage III.50 The forespores also synthesize a group 
of small acid-soluble proteins (SASPs) mostly during stage III, which contribute to the 
UV-resistance of spores. Importantly, each species of Bacillus group bacteria has 
species-specific sequences of SASPs, which can be used for species identification.51 In 
stages IV and V, the mother cell provides spore coat proteins, while the cell wall and 




The multiple layers covering the spore allow it to maintain stability in harsh 
environments.49 Lastly, dipicolinic acid produced at the last stage of spore maturation 
plays a significant role in protecting spores, especially spore DNA.52 These stage-
specific products have been used to determine sporulation stages.53–57   
In addition to the synthesis of specific enzymes and metabolites during 
sporulation, another noteworthy aspect of spores is substantially high resistance to 
numerous biochemical and physical stressors, including chemicals, heat, UV radiation, 
mechanical disruption and so forth.48,50 Determination of the spore resistance to these 
environmental stressors can distinguish spores from vegetative cells58–60. With such 
resistance, Bacillus spores can endure for a long time period and be an effective means 




1.3   Research objectives and significance  
Based on the knowledge of two important biological processes—sporulation and 
EV biogenesis—I aim to examine possible correlations between these processes.  
Under this main goal, the first sub-objective is to confirm the production of EVs at 
diverse growth stages of B.subtilis, especially during sporulation. It is a significant step 
because EVs from sporulating cells have not been reported. In this step, a specific 
isolation technique and high-resolution microscopy are required to accommodate the 
nano-scale size of the EVs. After verifying the presence of EVs, my second sub-
objective is to optimize the cell preparation and EV isolation procedures from 
vegetative and sporulating phases to obtain optimal and comparable amounts of EVs. 
Vegetative phase Sporulation phase Spore 
EVs 









With the EVs collected from vegetative and sporulating cells, my third sub-objective 
is to quantitatively compare the proteomes of EVs produced at the two different stages 
using tandem MS and bioinformatics techniques. The protein profiling may suggest 
natural functions of bacterial EV. Additional characterizations of EV proteins have 
been performed by enzymatic assay and western blotting in order to support MS-based 
analysis. My last sub-objective is to observe interaction between EVs and B. subtilis 
cells. Observation of their communication would provide evidence for the transfer 
mechanisms of EV contents into bacterial cells.   
Unlike Gram-negative bacterial EVs, little is known about Gram-positive 
bacterial EVs. Foundational knowledge is vitally needed. In this study, Gram-positive 
bacterium B. subtilis is used, for which there is the most extensive genomic and 
proteomic information. This study on the relationship between EV production and 
sporulation is expected to enhance understanding of B. subtilis biology and accelerate 






Chapter 2:  Isolation and characterization of EVs shed by 
vegetative and sporulating B. subtilis 
2.1  Introduction  
Gram-negative bacterial OMV production has been observed under a wide 
range of growth stages and conditions including in liquid media,9,13 agar plates,62 in 
biofilms17, within eukaryotic hosts63,64 and even during bacteriophage infection.65 
Moreover, OMV biogenesis has been found to be stimulated by environmental changes 
such as nutrient depletion66 and treatment with antibiotics.67 Gram-positive bacteria 
were also reported to shed EVs into liquid media during exponential growth phase, 
stationary phase, and in biofilms,6,7,21 but not after death.6  However, the effect of 
collecting time points on EV production for has not yet received attention. In addition, 
it is still not known whether EVs are produced even during sporulation. 
The most popular technique for isolating bacterial EVs is differential 
ultracentrifugation supported by membrane filtration.68 Centrifugation at relatively low 
speed (≤ 15,000 ×g) removes cells and cell debris, followed by spinning at high speed 
(≥ 50,000 ×g) to pellet the EVs for the last centrifugation step. In addition to the speed, 
diverse other factors such as distance from rotation axis, rotor type, and viscosity of 
solution have decisive effects on the size, homogeneity, purity, yield, and membrane 
integrity of vesicles.69 Thus, one need to take account of these factors for optimizing 




through 0.22-0.45µm filtering devices in order to minimize remaining 
contaminants.70,71 Density gradient centrifugation using sucrose or OerptiprepTM for 16 
– 20 hours may follow the last pelleting step for more stringent purification.72 However, 
the adequate centrifugation time is still uncertain. With inadequate time, some EVs 
may not be deposited in a density fraction for EVs, while contaminants may stay in the 
same density fraction as EVs.69  
Size exclusion chromatography (SEC) has recently emerged as an efficient 
alternative method that provides EVs of relatively homogeneous size with high 
purity.27 This method is considered ideal for therapeutic applications of bacterial EVs, 
in which purity is critical.73 A simplified single-step isolation method using SEC has 
been also proposed.74 However, chromatographic separation may decrease the yield of 
EVs because of the dilution into several fractions and non-specific interaction with the 
column beads.75  
Morphological characterization of purified EVs is indispensable in order to 
confirm the presence and purity of isolated EVs. For this step, microscopic techniques 
with high resolution are required because of the nano-scale size of EVs. Transmission 
or scanning electron microscopy is commonly chosen and, rarely, atomic force 
microscopy can be also applied for 3 dimensional profiling.76 Further, electron 
microscopy with embedding technique has been used to detect shedding and fusion 
events of EVs from a cell.6,15  
In this chapter, EVs were isolated at the stationary phase and the sporulating 
phase separately in order to observe the production of EVs across those developmental 




vegetative and sporulating phases based on the differential ultracentrifugation method. 
The collected EVs were further characterized by negative staining TEM, protein and 
lipid assays. 
2.2  Materials and Methods 
2.2.1  Cell cultures of vegetative and sporulating B. subtilis 
B. subtilis 168 (Ind-, Tyr+, ATCC #23857, Manassas, VA) cells from freeze-
dried stock were plated on brain heart infusion of 37 g in 1 L distilled water (BHI, 
Becton Dickinson, Franklin Lakes, NJ) with 1.5% agar. All cell cultures were produced 
at 37°C. For vegetative growth, a single colony was transferred to 5 mL of BHI broth 
(37 g BHI in 1 L distilled water) for sub-culture. Cells from the sub-culture were 
incubated in 500 mL BHI broth for 12 h, unless noted otherwise, and centrifuged at 
10,733 ×g for 25 min at 4°C. The cell pellet was resuspended in Dulbecco’s phosphate 
buffered saline (PBS) and pelleted at the same centrifugation as described above. The 
washed cells were resuspended in BHI-based sporulation medium and subsequently 
incubated for 12 h. BHI-based sporulation medium was produced by modifying SM 
resuspension medium.77 Briefly, this medium consists of 6 g BHI (~32% of normal 
BHI broth), 12 mg MnCl2, 4.8 g MgSO4, and 0.2 g CaCl2 in 500 mL water. The cells 
grown in sporulation medium were pelleted and washed as done for the vegetative cells. 
The supernatants from vegetative and sporulating cultures were subject to EV isolation, 
separately. Three biological replicates were prepared for cells and EVs at vegetative 




using serial dilutions. The production of spores was detected using Schaeffer-Fulton 
staining phase contrast microscopy.78  
2.2.2  EV isolation  
EVs were collected from vegetative and sporulating cell cultures according to 
published methods7,21 for Gram-positive bacterial EVs, with slight modifications. 
Briefly, the collected supernatants from cell cultures were filtered using a 0.22 µm 
bottle-top vacuum filter (Corning, Tewksbury, MA) to remove remaining cell debris. 
EVs were pelleted by ultracentrifugation for 90 min at 150,000 ×g at 4°C and the 
resulting pellet was washed with PBS at the same condition of ultracentrifugation 
(OptimaTM LE-80K ultracentrifuge with 70Ti rotor, Beckman Coulter, Indianapolis, 
IN). Each pellet was resuspended in PBS. Lastly, the isolated EVs were washed with 
PBS through a 100 kDa Amicon filter three times. The isolated EVs were stored in PBS 
at -80°C until further use. 
2.2.3  Protein / lipid assays 
Protein concentrations of purified EVs were determined using a Pierce BCA 
protein assay kit (Thermo Fisher Scientific, Rockford, IL) according to the user manual. 
An aliquot of EVs was incubated with 5µM DiO lipophilic dye (Invitrogen, Grand 
Island, NY) in PBS for 1 h at room temperature in order to estimate lipid contents of 
EVs. Amounts of vesicular lipids were measured using F-4500 fluorescence 
spectrophotometer (Hitachi, Tokyo, Japan). Excitation wavelength was fixed at 498 nm 
and emission fluorescence intensity was measured at 510 nm. The total intensities of 




2.2.4  Transmission electron microscopy (TEM) 
Negative staining TEM was used in order to analyze the presence and purity of 
isolated EVs. Bacitracin (1%) was applied on a carbon-coated formvar grid to spread 
vesicles. Tenfold diluted EV solutions were added on the grid and washed three times 
by double-distilled water. The EV samples on the grids were strained with 2% uranyl 
acetate for 30 sec. Images of EVs were captured at an accelerating voltage of 80 keV 
on a Zeiss EM10CA TEM (LEO Electron Microscopy, Thornwood, NY).  
For the thin-sectioning TEM, sporulating cells prepared as described above were 
primarily fixed with 2% glutaraldehyde for 1 h at room temperature followed by 12 h 
at 4°C and they were additionally washed with PBS by three cycles of resuspension, 
followed by centrifugation at 10,000 x g at room temperature. For secondary fixation, 
the pellet was then resuspended and incubated in 1% OsO4 in cacodylate buffer for 1 h 
and excess OsO4 was removed by washing with double-distilled water three times as 
in the above PBS washing steps. The cells were then stained with 2% uranyl acetate for 
1 h and pelleted. The pellets were dehydrated in a serial ethanol solutions of 35, 50, 70, 
95 and three changes of 100% for 10 min per each concentration. After dehydration, 
the samples were embedded in Spurr's resin and polymerized at 70°C for 10 h 80. Thin 
sections were obtained using a Reichert Ultracut E ultramicrotome with a diamond 
knife (Leica, Vienna, Austria) and placed on carbon-coated formvar grids. The sections 






2.3 Results and discussion 
B. subtilis 168 cells were grown in BHI liquid medium under vegetative growth 
for 3, 5, 10, 12, and 17 hours. EVs were collected from the cells at each time point in 
order to find optimal collecting time for adequate amount of EVs at vegetative growth 
phase. The cells were in exponential growth phase at 3 h, while they were in stationary 
phase at 5, 10, 12, and 17 h.  EVs were detected at all time points by negative staining 
TEM (Figure 5). 
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Figure 5. TEM images of the isolated EVs at different growth times. EVs isolated 
from vegetative cultures after (A) 3 h, (B) 5 h, (C) 10 h, (D) 12 h, (E) 17 h and EVs 




 The pellet of EVs from B. subtilis 168 has been observed to be brownish.6 In 
this study, the resulting pellets from 3 and 5 h cultures were translucent while those 
from 10, 12 and 17 h cultures were brownish. Growth time of 12 h was selected because 
the amounts of EVs from 3 and 5 h cultures were inadequate for proteomic analysis 
and some cells from 17 h culture were observed to have already started sporulation 
based on phase contrast microscopy. Also, a growth time of 12 h has been previously 
reported to be optimal for EV isolation from B.subtilis.6 In order to collect EVs from 
sporulating cells, the cells grown for 12 h in BHI medium were washed and additionally 
grown in BHI-based sporulating medium for 12 h. The amount of cells grown in 
vegetative medium for 12 h was [2.9 ± 0.1] x 107 CFU/mL (n=3) and the cells 
additionally grown in sporulating medium for 12 h was [3.1 ± 0.4] x 108 CFU/mL (n=3). 
The higher CFU in sporulating culture is presumably due to continuous growth of some 
cells and germination of some spores. An alternative cell counting method using 
hemocytometer resulted in significant uncertainty because of non-specific shapes of 
endospore-forming cells. Thus, more reliable cell counting methods may be needed to 
obtain an absolute comparison between the amounts of cells in the vegetative and the 
sporulating media. 
The EV isolation method was slightly modified from previous publications.6,7,21 
A minimum ultracentrifugation time at the input speed is reported to be 1 h for EV 
isolation.82 However, the stability of EVs decreases as the isolation time increases. 
Considering both factors, an ultracentrifugation time of 90 min was selected. After an 
initial washing step by ultracentrifugation, EVs were additionally washed by buffer 




cell culture was also applied to the sporulating cell culture grown in BHI-based liquid 
sporulaing medium. The resulting pellet at the ultracentrifugation step was also 
brownish. Relative intensities of EV lipid contents were detected by labeling EVs with 
DiO lipophilic dyes in order to estimate the amout of EVs produced by comparable 
numbers of vegetative and sporulating B. subtilis. The lipid contents of EVs were 
determined as [6.7 ± 0.1] x 10-7 (DiO intensity/CFU, n=3) at vegetative phase and [1.3 
± 0.4] x 10-7 (DiO intensity/CFU, n=3) at sporulating phase. Vegetative cells showed 
higher EV production than sporulating cells. However, lipid contents per cells were 
possibly underestimated because sporulating cells have a chance to be germinated 
during CFU measurement.  
The presence and purity of EVs collected at several time points during 
vegetative growth and sporulation were examined by negative staining TEM (Figure 
5). Although the amount of EVs seen varied, EVs were detected across a broad range 
of cell growth time including the sporulating phase. In order to evaluate size 
distributions of vegetative EVs and sporulating EVs, Image J was used to estimate 
diameters of EVs in TEM images of 200 EVs from the 12 h vegetative culture and 200 
EVs from the 12 h sporulating culture.83 Both populations were distributed mostly 
between 30 and 150nm and centered at 60nm (Figure 6). The size distributions of two 
EV groups were similar to each other. Diameter measurement from TEM images has 
been proposed to underestimate the size relative to other hydrodynamic 
measurements.6,84,85  Other microscopic techniques such as cryo-EM may be applied if 





As reported by others,6,32 some flagella were observed in TEM images with 
both vegetative and sporulating EV populations. B.subtilis is known to have highly 
enriched flagella on the cell surface, and it is difficult to avoid co-isolating flagella with 
EVs. Less flagella were detected from the cells harvested at shorter growth times, but 
the amount of EVs was also reduced. Density gradient ultracentrifugation is often used 
for further purification. However, flagella have been observed to remain after the 
density gradient step.6 Even after the density gradient step, flagella have been identified 
either by TEM or by MS-based proteomics. In the proteomic study flagella-associated 
proteins are discarded. 
With the detection of EVs from sporulating B.subtilis culture, we speculated 
that EVs may come from either the sporulating cell membrane or the premature 
endospore membrane in the mother cell. In order to capture the event of EV release, 

































Figure 6. EV diameter estimations from TEM using Image J. (A) vegetative EVs 




Some unidentified extracellular blebs in a range of EV sizes were detected from 
sporulating cells (figure 7A, B), but the images were not sufficiently clear to confirm 
the shedding event of EVs. It is possible that EVs blebbing out from the cells might be 
disrupted during the sample preparation for thin-sectioning TEM. Putative extracellular 
and intracellular blebs were also observed from free spores released from mother cells 
(figure 7C, D) However, mature spores have a weak likelihood to shed EVs because 
the released free spores are firmly covered by cortex, spore coats and exosporium over 
A B 
C D 
Figure 7. Thin-sectioned TEM images of spores and endospore-containing cells. 
Endospore-containing cells with (A) a putative released EV and (B) putative EV 
fusing out of a cell. Free spores with unidentified (C) outer and (D) inner blebs 




the spore membrane. Better techniques for thin-sectioning sample preparation and 
TEM examination would answer the question whether EVs are also shed from the 
prespore in a cell.  
 
2.4 Summary 
In this chapter, the EV isolation method was optimized and the isolated EVs 
were microscopically characterized. B. subtilis cells were observed to shed EVs at 
several different stages including the sporulation phase with size distributions that fall 
within the range proposed from other bacterial species.86 These observations suggest 
that EV biogenesis is a continuous and universal process over the broad cellular life 
span of B. subtilis. Also, EV production can be assumed to be a highly conserved 
biological phenomenon in bacteria. The relative amount of EVs produced from 
sporulating cells was comparable with that from vegetative cells, which indicates that 
the cells are actively shedding EVs even during sporulation.   
Due to technical limitations, contamination with flagella occurred in all EV 
extracts and the shedding event of EVs from a cell was not clearly detected by TEM. 
Improvement of methods for these issues may be implemented using alternative 





Chapter 3:   Analysis of protein cargo in EVs shed at 
vegetative and sporulating stages 
3.1  Introduction 
Since B. subtilis cells naturally produce EVs across diverse cellular growth 
stages, EVs are expected to have biological significance. Tandem MS-based 
proteomics is an indispensable technique to understand diverse aspects of EVs 
including their functions and biological processes in which EV proteins are involved.   
Proteomics refers to the large-scale study of proteins, covering structural 
information, cellular functions, variations, modifications of the proteins and 
quantitation. Although various techniques contribute to proteomics, such as 
electrophoresis, microarray and microscopic imaging, current proteomic analysis 
mostly relies on MS.87,88 MS analyzes both small and large molecules measuring the 
mass-to charge ratio (m/z) of ionized samples. Importantly, the analytes are required to 
be ionized and transferred into the gas-phase for mass spectrometric measurements. 
MS instrumentation includes an ion source, a mass analyzer and a detector. 
Instrumentation settings can be optimized depending on characteristics of each analysis, 
and they affect the results significantly. Especially, it is important to determine 
evaluation parameters such as resolution, mass accuracy, and sensitivity in the mass 
analyzer.89 Ion trap (including linear ion trap and orbitrap), time-of-flight, quadrupole, 




analyzer performs the m/z in a distinctive way. Tandem MS combines two or more 
mass analyzers and is often used in combination with a separation tool. The tandem 
MS instrumentation of choice in this study was hybrid ion trap-orbitrap (LTQ-orbitrap 
XLTM, San Jose, CA) with electrospray (or nanospray) ionization (ESI). ESI  is a ‘soft’ 
ionization technique that produces ions in the gas-phase without fragmentation.90 In the 
system, highly charged droplets are sprayed under an electric field and ions are 
converted into the gas phase as the solvent is evaporated. This method is the most 
compatible interface for LC-MS and extends the mass range of the analyzer with 
multiple charges.91   
The LTQ-Orbitrap hybrid mass spectrometer is a combination of a linear ion trap 
and an Orbitrap mass analyzer.92 The LTQ is a 2-dimensional quadrupole ion trap, 
which is constructed with 4 rods and uses oscillating direct current and radio frequency 
potentials.89,93 In the LTQ, the trapped ions in a specific m/z range are ejected using a 
mass selective instability operation.93,94 The LTQ has advantages in ion trapping 
efficiency, ion-storage capacity, ion-ejecting efficiency, scan speeds, and detection 
sensitivity compared to 3-D ion trap.93 The Orbitrap is also an ion trap mass analyzer 
consisting of a central spindle-like electrode and a coaxial barrel-like outer electrode.95 
The orbital trapping of ions occurs around the central spindle-like electrode with an 
electrostatic field. The trapped ions undergo harmonic oscillations and the frequencies 
of the oscillations are dependent on m/z values. The ion frequencies are acquired by 
the image current and converted to mass spectra by fast Fourier transform. The orbitrap 
has significant enhancements in mass resolution, mass accuracy, dynamic range, and 




Three major approaches for MS-based proteomics are top-down, middle-down, 
and bottom-up. The top-down approach analyzes intact proteins without digestion, 
while the middle-down identifies relatively large peptides in a range of 3-20kDa, and 
the bottom-up processes small peptides produced by practically complete enzymatic or 
chemical cleavages.96 Among these methods, the bottom-up approach has mostly been 
used for global profiling of proteins or proteomes from complex mixtures.97 When 
coupled with high-performance liquid chromatography (HPLC), the bottom-up 
approach has higher separation efficiency and better sensitivity compared to the 
others.88,97,98  
In a common workflow of MS-based bottom-up proteomics, biological samples 
of protein mixtures are digested to peptides either by enzymatic or by chemical means. 
Enzymatic digestion by trypsin is the most widely used method. The peptide mixtures 
are separated generally by one or multiple dimensional separation techniques, 
including electrophoresis and/or chromatography. Among various separation 
techniques, LC has advantages in efficiency of a continuous separation for numerous 
proteins, and compatibility with MS.88 In the subsequent MS analysis, peptide fractions 
are ionized by ESI system and analyzed by tandem mass analyzers. The first stage of 
mass analysis scans precursor ions and provides mass to charge ratios of injected 
peptides or proteins (MS1). Precursor ions of interest are selected to be fragmented. 
After fragmentation, product ions are formed by bond cleavages and scanned in the 
second mass analyzing system (MS2). Types of product ions vary depending on 
fragmentation methods (Figure 8). The most common fragmentation technique is 




as helium or nitrogen,99 resulting in peptide backbone cleavages mostly at the peptide 
bonds.  
The resulting mass spectra are processed to identify peptides and proteins. The 
MS1 and MS2 spectra of a peptide mixture contain massive amount of information, 
which needs to be analyzed by computational techniques. The raw mass spectra are 
first converted to data processing formats, which are then searched against protein 
sequence database. Search algorithms match the experimental tandem mass spectra 
with theoretical MS2 spectra, which are generated from a list of possible peptide 
sequences and their fragments based on a selected database. There are diverse 
automated database searching engines such as MASCOT,103 SEQUEST,104 
X!Tandem,105 and PepArML.106 More recently, new types of search engines that match 
observed spectra with consensus spectra based on previous identifications have also 
emerged and been reported to improve searching efficiency and accuracy.107,108 All 
types of search engines score the searched peptides and then report top-scoring peptides, 
which are referred to peptide-spectrum matches (PSMs).107  
The selection of a database affects peptide identifications considerably, because 
assignment of peptides is limited to sequences in the database.100 UniProt/SwissProt,101 
Figure 8. Fragmentation patterns of peptides in tandem mass spectrometry. Product 




RefSeq,102 and UniProt/TrEMBL101 are popular examples of databases. 
UniProt/SwissProt and RefWeq are well-curated sequence databases based on 
experimental evidence, while TrEMBL contains sequences translated from genomic 
database or from proteins submitted to UniProt/SwissProt but not yet curated. The 
translated and uncurated databases provide a large number of sequences. These 
databases may require additional filtering because of higher redundancies. Curated 
databases, however, allow analysis focusing on biologically significant reference 
proteins with less redundancy. In the present study, reviewed sequence database from 
Uniprot/Swissprot was selected in order to perform reliable protein identification with 
evidence for relevant functions of proteins. 
Subsequent to sequence searching, the significance of the acquired peptide 
identifications (IDs) is validated via various algorithms. Although top-scoring peptides 
are determined by search engines, the resulting PSMs may still be incorrect. Thus, the 
resulting peptide IDs need to be further evaluated. The most commonly used statistical 
values to validate putative IDs are p-value and false discovery rate (FDR).109 By 
definition, p-value is the probability of obtaining a result equal to or more extreme than 
the actual observation, when assuming the null hypothesis is true. In the validation of 
PSMs, the null hypothesis can be that the peptide was not found by the MS analysis. 
Therefore, a low p-value indicates the possibility of the data occurring by chance is 
small when the null hypothesis is correct. For example, if one sets a threshold of p-
value ≤0.05, a 5% chance of false positives is allowed in a result. However, p-value 
threshold is usually considered as incomplete statistical validation value for large-scale 




positives when one processes numerous tests. In order to overcome the multiple testing 
problem, p-value to each test may be adjusted or corrected based on the sample size. 
Among diverse approaches for correcting p-values, FDR is mainly used.110 FDR is a 
ratio of false PSMs versus the total number of PSMs above a scoring threshold. Thus, 
FDR reduces the number of false positives by controlling the number of false 
discoveries from significant tests rather than all tests. In MS-based bioinformatics, a 
target-decoy method is often used to estimate FDR.111 In this method, a decoy database 
is composed of reversed or shuffled sequences.111 False peptide IDs are evenly 
distributed in both target and decoy databases, and then PSM FDR is determined as the 
number of decoy hits divided by the number of target hits. 
 Next, proteins IDs are inferred by grouping peptide IDs filtered at a given 
scoring criteria. For protein inference, ‘two-peptide rule’ is commonly applied, which 
requires a protein to contain two or more filtered peptides. More recently, ‘single-
peptide rule’ has also received attention.112 Proteins can be inferred by one or more 
peptides with this method, but peptide threshold is more stringent and lengths of 
peptides are also considered.  Protein IDs are also evaluated by protein-level FDR 
estimation. 
 In addition to qualitative protein identification, quantification has become a 
fundamental topic in MS-based proteomics. MS was not originally designed for 
quantitative analysis because ESI efficiency and detectability of proteins or peptides 
are variable.113 In recent decades, however, MS has emerged as a standard method for 
quantitative proteomics due to improvements in data processing methods.114 Strategies 




quantitation. The most popular labeling method is stable-isotope labeling, which 
introduces signature mass tags to peptides or proteins by replacing specific atoms by 
their isotopes.114–118 Labeling quantification can be either relative or absolute.  
 Label-free techniques attempt to quantify proteins or peptides without isotopic 
labeling.114 Among various approaches of label-free quantification, spectral counting 
based on the number of PSMs has recently received substantial attention and is reported 
to result in a great dynamic range for quantitation and high reproducibility.119,120 
Spectrum counting is especially powerful for comparing large data sets, because the 
required information of spectral counts for each protein can be provided by search 
engines during protein identification.114 
 In this chapter, protein cargos of EVs from vegetative cells and sporulating cells 
were analyzed by bottom-up HPLC-MS/MS. The resulting spectra were processed by 
bioinformatics tools, and proteins from the two EV groups were quantitatively 
compared with a label-free spectral counting technique. 
3.2  Materials and Methods 
3.2.1  Proteolysis 
EVs collected from all biological replicates at vegetative and sporulating phases 
were aliquoted for proteomic analysis. They were then lysed by 3 cycles of sonication 
for 40 sec on ice in 50 mM NH4HCO3, pH 7.8 with 8M urea and 1X protease inhibitor 
cocktail, (Sigma-Aldrich, St. Louis, MO). Each lysate was washed with 50 mM 




concentration down to 8 mM. Reduction of the lysates was performed with 20 mM DL-
dithiothreitol for 30 min at 56°C, followed by alkylation with 40 mM iodoacetamide in 
the dark for 30 min at room temperature. Subsequently, the samples were digested by 
Sequencing Grade Trypsin Gold (Promega, Madison, WI) for 16 h at 37°C (enzyme to 
protein ratio: 1 to 30, w/w).   
3.2.2  Peptide analysis by HPLC-MS/MS 
 The tryptic peptides from the EVs were analyzed on a Shimadzu Prominence 
nano-HPLC (Shimadzu Scientific Instruments, Columbia, MD) interfaced with an 
LTQ-Orbitrap XL hybrid mass spectrometer (Thermo Fisher Scientific, San Jose, CA). 
Peptide mixtures from EVs containing 1 µg protein were injected onto an Acclaim 
PepMap 300 C18 trapping column (Dionex, Sunnyval, CA), stabilized and desalted by 
95% solvent A (97.5% H2O, 2.5% acetonitrile, and 0.1% formic acid) with 5% solvent 
B (97.5% acetonitrile, 2.5% H2O, and 0.1% formic acid) for 10 min. Three technical 
replicates were injected from each of 3 biological replicates for EVs shed by vegetative 
and sporulating B. subtilis cells. The peptides were then separated on a reverse phase 
C18 analytical column (300 Å , 150 × 0.15 mm, Grace Davison Discovery Sciences, 
Columbia, MD) with a linear gradient increasing from 5% to 40% solvent B for 120 
min, followed by a ramp from 40% to 85% for the next 25 min. The flow rate was set 
at 500 nL/min. Precursor ion scans were acquired in the Orbitrap with a resolution of 
30,000 at m/z 400. The nine most abundant precursor ions were automatically chosen 
and fragmented by CID with a normalized collisional energy of 35 in each cycle. 




were averaged per a spectrum and a dynamic exclusion of 1 repeat count was enabled 
to exclude precursor ions previously scanned within 180 sec. 
3.2.3  Bioinformtics 
 The resulting mass spectra were searched using the PepArML meta-search 
engine106 in order to identify peptides and proteins. PepArML combined the results 
from seven search engines: Mascot, X!Tandem, KScore, MyriMatch, OMSSA, SScore, 
and InsPecT. A reference database of B. subtilis 168 proteins including 4,243 reviewed 
sequences was acquired from the UniProtKnowledgeBase (UniprotKB, July 2014). In 
the search parameters, trypsin was chosen for the proteolytic agent with 
carbamidomethylation of cysteine set as fixed modification and oxidation of 
methionine as variable modification. Maximal charge state was set as 4, and 1 missed 
cleavage was allowed. Additionally, precursor ion tolerance was ± 2 Da, while 
fragment ion tolerance was ± 0.6 Da. Flagella-associated proteins had non-overlapping 
identities and were removed. The search results from 3 technical replicates of each 
biological replicate were combined and filtered at 5% PSM FDR,111 which was 
determined by PepArML. The proteins were required to contain two or more peptides, 
resulting in the final protein FDR ≤ 0.25%. Proteins identified from two or more 
peptides were then filtered at the FDR-corrected p-value ≤ 0.05 for multiple testing.120 
Subcellular locations, molecular functions, and biological processes of these proteins 
were annotated by the Protein Information Resource (PIR, pir.georgetown.edu) based 
on Gene Ontology (GO) and UniprotKB. Database for Annotation, Visualization and 
Integrated Discovery (DAVID) bioinformatics resources121 were also used for 




The proteins identified with statistical significance were further analyzed for 
comparison of relative abundances between the vegetative EV proteome and the 
sporulating EV proteome. Spectral counting was processed based on the number of 
PSMs using an in-house software PepArML Spectral count 1.6.2. With this software, 
the difference in spectral counts of each protein between EVs from vegetative and 
sporulating cells was expressed as a ratio of spectral count, Rsc, according to the 
equation : Rsc = log2[(n2+1.25)/(n1+1.25)] + log2[(t1-n1+1.25)/(t2-n2+1.25)], where n1 
and n2 are the spectral counts of each protein from the two groups; t1 and t2 are the 
total numbers of spectra of the two groups; and 1.25 is a correction factor.120 
Differential p-values of spectral counts were also determined by the Fisher exact-test. 
3.2.4  Western blot analysis 
Vegetative and sporulating B. subtilis cells and the two EV types were prepared 
as described in chapter 2 and lysed. Protein concentration of each lysate was 
determined by a BCA protein assay (Thermo Fisher Scientific, Rockford, IL). The four 
lysates were separated by one-dimensional SDS-PAGE. Each lysate containing 20 µg 
total proteins were mixed with 2x Laemmli Sample Buffer (1:1, Bio-Rad, Hercules, 
CA) containing 5% β-mercaptoethanol, and the mixtures were incubated at 70°C for 
15 min. The samples were then loaded on an 8−16% Criterion precast gel (Bio-Rad, 
Hercules, CA) and separated at 200 V for 40 min.  Electrotransfer was performed for 
protein bands from the gel to to a PVDF membrane (EMD Millipore, Billerica, MA) at 
100 V for 1 h. The blots were blocked in 5% BSA and incubated with a primary 
antibody, a rabbit anti-B. subtilis alanine dehydrogenase polyclonal antibody at 




The primary antibody was tested with purified B. subtilis L-alanine dehydrogenase 
(Sigma-aldrich, St. Louis, MO). Secondary incubation was performed using an anti-
rabbit IgG, horseradish peroxiadase (HRP)-linked antibody at 1:2,000 dilution of a 
commercial stock solution (Cell signaling Technology, Beverly, MA). The blots were 
lastly incubated with SusperSignal West Dura extended duration substrate (Thermo 
Fisher Scientific, Waltham, MA) for detecting HRP.  Image Lab System (Bio-Rad) 
with Gel-Doc program (Kodak Molecular Imaging Systems) was used for visualization 
of the blots. Relative intensities of the blots were estimated by Image J software.83 
3.2.5  Alkaline phosphatase (AP) activity assay 
 AP enzymatic activities in EVs were determined according to Lowry’s 
colorimetric assay.122 EVs containing 30 µg of proteins from each biological replicate 
were lysed as described above. The EV lysate was incubated with 100 µM p-
nitrophenyl phosphate disodium salt hexahydrate (MP Bio, Santa Ana, CA) in AP assay 
buffer (1 M Tris-HCl, pH 7.8, 50 µM ZnCl2, 10 mM MgSO4) for 1 h at room 
temperature in the dark. The incubation was stopped with 0.5 M NaOH and UV 
absorbance at 405 nm of the samples was measured.  
3.3  Results and discussion  
3.3.1  Characterization of EV proteins 
 Proteins of EVs from vegetative and sporulating cells were analyzed by HPLC-




forty nine proteins were identified based on two or more distinct peptides from 
vegetative EVs and 341 proteins from sporulating EVs with a final protein FDR of at 
most 0.25%. Out of a total of 417 unique proteins, 273 proteins were shared by the two 
groups. The identified proteins were additionally filtered with an FDR-corrected p-
value ≤ 0.05, resulting in 156 proteins from vegetative EVs and 185 proteins in 
sporulating EVs (Appendix 1). The two EV groups shared 133 proteins out of 208 
proteins.  
Subcellular locations and molecular functions of the filtered proteins were 
annotated with GO annotation using PIR (Figure 8, Figure 9). The subcellular 
locational distributions of the proteins were similar between vegetative EVs and 
sporulating EVs (Figure 9). The greatest number of proteins was sorted to membranes, 
followed by cytoplasm in both cases. A substantial difference in the ribosome category 
is due to more various and abundant ribosomal proteins in the sporulating EVs 
(Appendix 1). The annotations according to molecular functions of proteins were also 
similar in both groups (Figure 10). The total numbers of proteins identified with 
statistical significance and the numbers of unique peptides from the two populations of 
EVs were not substantially different in the proteomic results.  In addition, more than 
70% of total proteins identified from each group was present in both EV populations. 






Figure 9.  Subcellular locational distributions of identified proteins based on Gene 
Ontology (FDR-corrected p-values ≤ 0.05). The most highly assigned 10 locations from 
each EV group were selected (annotation p-value ≤ 0.05). Some proteins were located 
to more than one category. Unclassified proteins were not included. *proton-
transporting two-sector ATPase complex.  
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Figure 10. Molecular functional annotations of identified proteins based on Gene 
Ontology (FDR-corrected p-value ≤ 0.05). The most highly populated 10 functions 
from each EV group were selected (annotation p-value ≤ 0.05). Some proteins were 
located to more than one category. Unclassified proteins were not included.  


































Proteins in vegetative EVs (156 total)




3.3.2  Relative abundances of proteins 
Relative abundances of identified proteins were determined by spectral 
counting and expressed as Rsc, which is the log2 ratio of spectral counts for each protein 
in vegetative EVs versus sporulating EVs or that in sporulating EVs versus vegetative 
EVs. Proteins with Rsc >1 in each case were considered to have substantially higher 
abundances (>2-fold) in a group. Rsc was calculated for the 208 total distinct proteins. 
Seventy-five proteins out of 208 had significantly greater abundance in vegetative EVs 
than sporulating EVs, while 124 proteins had greater abudance in sporulating EVs with 
a high reliability (Table 1, 2, and Appendix 1). However, it is noteworthy that 70% of 
the cells in sporulating culture contained endospores.  
 GO biological processes for the proteins with differential abundances were 
assigned using PIR (Figure 11). Proteins more abundant in vegetative EVs were mostly 
involved in metabolic processes. Also, a substantial number of proteins in vegetative 
EVs were annotated to participate in processes of response to stimulus. For the proteins 
more abundant in sporulating EVs, however, metabolic functions were significantly 
decreased. Instead, proteins involved in processes critical for cellular differentiation 
such as ribosome biogenesis, sporulation, locomotion, and cell division were enriched. 
The number of proteins for response to stimulus remained similar to that of vegetative 
EVs. Functional pathways according to KEGG for proteins with different abundances 
were clustered using DAVID.121 Five functional pathways from each group were 
annotated with a reliable annotation p-value (<0.05) (Table 3). The pathways 
associated with metabolism were mostly enriched in vegetative EV proteins, while 




sporulating EV proteins. Therefore, the relative abundances of individual proteins 
differed significantly between the two EV groups. The proteins with differential 
abundances were observed to be involved in different biological processes. These 
results indicate that B.subtilis EVs carry different protein components depending on 
the developmental phases of parental cells. 
 
Table 1. List of proteins with greatest 50 RSC from vegetative EVs (FDR-corrected p-
value ≤ 0.05) 





P80860 Glucose-6-phosphate isomerase 6.8 
P37253 Ketol-acid reductoisomerase 6.2 
Q04789 Acetolactate synthase 6.0 
O34348 Fe(3+)-citrate-binding protein YfmC 5.9 
P37942 
Lipoamide acyltransferase component of branched-
chain alpha-keto acid dehydrogenase complex 
5.7 
P42199 L-cystine-binding protein TcyA 5.4 
P94521 Putative aminopeptidase YsdC 5.3 
O34924 Putative aminopeptidase YtoP 5.1 
P24327 Foldase protein PrsA 4.9 
P39751 MreB-like protein 4.4 
P80700 Elongation factor Ts 4.3 
P21881 
Pyruvate dehydrogenase E1 component subunit 
alpha 
4.2 
P19582 Homoserine dehydrogenase 4.2 
P80239 Alkyl hydroperoxide reductase subunit C 4.2 
P11998 6,7-dimethyl-8-ribityllumazine synthase 4.2 








O34866 Putative carboxypeptidase YodJ 4.0 
P26900 L-asparaginase 1 3.9 
P49814 Malate dehydrogenase 3.8 
P80879 General stress protein 20U 3.7 
P20429 DNA-directed RNA polymerase subunit alpha 3.64 
P40924 Phosphoglycerate kinase 3.63 
P45694 Transketolase 3.57 
O34860 RsbT co-antagonist protein RsbRB 3.54 
P28598 60 kDa chaperonin 3.45 
O32106 Probable cytosol aminopeptidase 3.43 
P05653 DNA gyrase subunit A 3.39 
P42974 NADH dehydrogenase 3.36 
P29727 GMP synthase [glutamine-hydrolyzing] 3.25 
P37870 DNA-directed RNA polymerase subunit beta 3.21 
P46911 
Menaquinol-cytochrome c reductase iron-sulfur 
subunit 
3.18 





P55910 L-lactate permease 2.96 
P26901 Vegetative catalase 2.94 
P09124 Glyceraldehyde-3-phosphate dehydrogenase 1 2.90 
C0SP94 
Putative ABC transporter substrate-binding 
lipoprotein YhfQ 
2.89 
P08495 Aspartokinase 2 2.80 
P42409 RsbT co-antagonist protein RsbRA 2.70 
P37941 2-oxoisovalerate dehydrogenase subunit beta 2.69 
P94356 Uncharacterized protein YxkC 2.65 
P54616 
Enoyl-[acyl-carrier-protein] reductase [NADH] 
FabI 
2.61 









Pyruvate dehydrogenase E1 component subunit 
beta 
2.54 
P22326 Tyrosine--tRNA ligase 1 2.50 
P54326 Phage-like element PBSX protein XkdF 2.47 
P13243 Probable fructose-bisphosphate aldolase 2.46 
P39594 Thiamine-phosphate synthase 2.43 
O34752 Prolipoprotein diacylglyceryl transferase 2.39 
P54547 Glucose-6-phosphate 1-dehydrogenase 2.39 
a   𝑅𝑆𝐶 = 𝑙𝑜𝑔2 (
𝑛𝑣𝑒𝑔𝑒𝑡𝑎𝑡𝑖𝑣𝑒+1.25
𝑛𝑠𝑝𝑜𝑟𝑢𝑙𝑎𝑡𝑖𝑛𝑔+1.25






Table 2. List of proteins with greatest 50 RSC from sporulating EVs (FDR-corrected 
p-value ≤ 0.05) 




P21466 30S ribosomal protein S4 8.5 
P21469 30S ribosomal protein S7 8.1 
P42919 50S ribosomal protein L2 7.6 
P26908 50S ribosomal protein L21 7.4 
P21473 30S ribosomal protein S15 7.3 
P19405 Alkaline phosphatase 3 7.0 
O31742 50S ribosomal protein L19 6.9 
O34469 Putative ATP-dependent helicase YeeB 6.9 
P46899 50S ribosomal protein L18 6.4 
P12877 50S ribosomal protein L5 6.3 
P19946 50S ribosomal protein L15 6.1 
P40406 Beta-hexosaminidase 5.8 







P42060 50S ribosomal protein L22 5.6 
O31550 
Dihydrolipoyllysine-residue acetyltransferase 
component of acetoin cleaving system 
5.4 
P04969 30S ribosomal protein S11 5.4 
Q45598 Uncharacterized protein YydD 5.4 
O34450 N-acetylglucosamine-6-phosphate deacetylase 5.4 
P54507 Spore coat-associated protein N 5.3 
P54332 Phage-like element PBSX protein XkdM 5.3 
P28628 Signal peptidase I S 5.24 
P05657 50S ribosomal protein L27 5.18 
P21475 30S ribosomal protein S18 5.18 
P46898 50S ribosomal protein L6 5.14 
O32258 Uncharacterized glycosylase YvbX 5.03 
Q06796 50S ribosomal protein L11 4.92 
Q45596 Putative exported peptide YydF 4.92 
P20166 PTS system glucose-specific EIICBA component 4.91 
O34662 Uncharacterized aminotransferase YodT 4.85 
P21467 30S ribosomal protein S5 4.85 
P94421 
Uncharacterized ABC transporter solute-binding 
protein YclQ 
4.85 
P54339 Phage-like element PBSX protein XkdT 4.83 
O31740 Ribosome maturation factor RimM 4.69 
P24137 Oligopeptide transport ATP-binding protein OppF 4.61 
P71021 Septum site-determining protein DivIVA 4.40 
P21464 30S ribosomal protein S2 4.23 
P45921 Uncharacterized protein YqbE 4.21 
P39456 L-cystine import ATP-binding protein TcyC 4.20 
P54560 DNA polymerase IV 2 4.20 











P17904 Serine-protein kinase RsbW 4.08 
P30949 Glutamate-1-semialdehyde 2,1-aminomutase 3.94 
P54340 Phage-like element PBSX protein XkdU 3.94 
P54327 Phage-like element PBSX protein XkdG 3.93 
O31927 
SPBc2 prophage-derived uncharacterized protein 
YopK 
3.79 
O32072 Uncharacterized protein YtwF 3.79 
P37471 Cell division protein DivIC 3.79 
P71012 PTS system fructose-specific EIIABC component 3.76 
Q45597 Fructose-1,6-bisphosphatase class 3 3.76 
b  𝑅𝑆𝐶 = 𝑙𝑜𝑔2 (
𝑛𝑠𝑝𝑜𝑟𝑢𝑙𝑎𝑡𝑖𝑛𝑔+1.25
𝑛𝑣𝑒𝑔𝑒𝑡𝑎𝑡𝑖𝑣𝑒+1.25






Table 3. Enriched KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways 
annotated in the two EV samples (p-values evaluate annotations) 
 












10 6.5E-06 Ribosome 22 1.6E-12 






Pyruvate metabolism 6 0.0053 RNA degradation 3 0.0082 














Figure 11. Biological process annotations of proteins with RSC >1 based on Gene 
Ontology. Biological processes of 75 proteins more abundant in vegetative EVs and 
124 proteins more abundant in sporulating EVs were annotated (annotation p-values 
≤0.05). Unclassified proteins were not included. 
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Proteins with higher abundance in vegetative EVs




3.3.3  Sporulation-associated proteins 
 
   Proteins known to participate in bacterial sporulation were found from the 
208 total proteins. Nine sporulation-associated proteins were highly enriched or only 
found in sporulating EVs (Table 4).  
 
Table 4. List of sporulation-associated proteins identified from sporulating EVs 
 
a Rsc of sporulating EV proteins over vegetative EV proteins. The proteins with Rsc >1 
were considered to be significantly more abundant in sporulating EVs.  
b Proteins identified only from sporulating EVs.  
*GO-BP annotation: Gene Ontology biological process annotation 






P19405 Alkaline phosphatase III 7.0 2.34E-63 
metabolic 
process 
P54507 Spore coat-associated protein Nb 5.3 4.37E-11 Sporulation 
P24137 
Oligopeptide transport ATP-binding 
protein OppF 
(Stage 0 sporulation protein KE) 
4.6 1.76E-11 Sporulation 
P71021 Septum site-determining protein DivIVA 4.4 1.46E-36 Sporulation 
P37471 Cell division protein DivICb 3.8 0.00032 cell cycle 
P24136 
Oligopeptide transport ATP-binding 
protein OppD 
(Stage 0 sporulation protein KD) 
3.8 2.97E-06 Sporulation 











(Stage V sporulation protein N) 




Five out of the 9 proteins, named spore coat associated protein N (tasA), 
oligopeptide transport ATP-binding protein OppD (alternative name: stage 0 
sporulation protein KD Spo0KD), oligopeptide transport ATP-binding protein OppF 
(stage 0 sporulation protein KE Spo0KE), septum site-determining protein DivIVA and 
alanine dehydrogenase (alternative name : stage V sporulation protein N spoVN) were 
clustered into sporulation according to GO annotation (Figure 11, Table 4). Concretely, 
tas A has been proposed to be secreted into the extracellular region during early 
sporulation and have a broad spectrum of antibiotic activities against other bacteria.123 
The observation of tas A in EVs suggests that shedding of EVs is a secretion pathway 
of tasA. Oligopeptide permeases OppD (Spo0KD) and OppF (Spo0KE) are parts of the 
oligopeptide transport system, which is a well-known recycling pathway in Gram-
negative bacteria.124 Furthermore, these proteins have been reported to play an 
important role in the initiation of sporulation.124–127 OppF has less impact than OppD, 
while OppD is indispensable for sporulation.126 General function of DivIVA is to 
control the cell division sites in either vegetative or sporulating B.subtilis.128 DivIVA 
has been observed to be critical for polar localization of the chromosome, which results 
in formation of an asymmetric septum during sporulation.128–130 Alanine 
dehydrogenase (spoVN) catalyzes oxidative deamination of L-alanine to pyruvate. This 
enzyme has been shown to function in absorption of L-alanine during sporulation.131 
The presence and the relative abundance of spoVN between vegetative and sporulating 
EV types were confirmed by western blotting with anti-B. subtilis spoVN antibody. 
SpoVN blot in sporulating EV lysate showed a stronger band intensity for spoVN than 




spectral counting result quantitatively (Figure 12, Table 4). Sporulating cell lysate also 
showed a higher spoVN band intensity relative to vegetative cell lysate, suggesting 
abundance of this protein in EVs reflects the developmental phases of B. subtilis cells 
(Figure S4). Identifications of these proteins annotated for sporulation were manually 





←spoVN (40 kDa) 































Figure 12. Western blotting of alanine dehydrogenase (stage V sporulation protein N, 
spoVN) in lysates of cells and EVs. (A) Western blot (8-16% SDS-PAGE) of spoVN 
in vegetative cell lysate (Veg.cells), sporulating cell lysate (Spo.cells), lysate of EVs 
from vegetative cells (Veg.EVs), and lysate of EVs from sporulating cells (Spo.EVs) 
with anti-spoVN polyclonal antibody. (B) Relative band intensities of spoVN blots. 
Intensities were determined relative to a band of positive control (purified B. subtilis 








Figure 13. MS/MS spectra of sporulation-associated proteins. (A) a peptide from 





In addition, sporulation stage-specific marker proteins were also identified with 
greater abundance in sporulating EVs. AP and β-galactosidase are considered as a 
sporulation stage II specific marker protein and a stage III marker protein, 
respectively.55,56,132,133 Enzymatic activities of AP and β-galactosidase have been 
widely used to screen the progress of sporulation.55,134 AP enzymatic activity assays 
for the EVs showed a qualitatively consistent result with the spectral counting (Figure 
14).  
 
Figure 14. Alkaline phosphatase activities from EV protein cargos (n=3). pNP: p-
nitrophenol  
 
Explainfully, AP enzymatic activities in sporulating EVs were substantially 









































only type of AP identified in this study, and it has been reported to have the greatest 
correlation with sporulation among the B.subtilis AP family.135 Unlike other APs, the 
production of AP III is independent of phosphate starvation and rapidly increases 
during sporulation.135 Cell division protein DivIC and spore coat polysaccharide 
biosynthesis protein SpsC were also reviewed to participate in sporulation according to 
previous publications,136,137 although they were not annotated for sporulation by GO 
annotation. DivIC has been shown to participate in the activation of gene expression 
controlled by transcription factors for sporulation, as well as in the cellular septum 
formation.136 SpsC has been proposed to be essential for spore-surface polysaccharides 
synthesis but it may need to be further studied.137 
Besides sporulation-specific proteins, the protein groups of phage-like element 
PBSX proteins, ribosomal proteins, and methyl-accepting chemotaxis proteins were 
also highly enriched in sporulating EVs (Table 2, Appendix 1). These proteins have not 
shown direct correlation with the sporulation process, but they may be indirectly related 
to it. First, the phage-like element PBSX proteins have been found to respond to 
stimulants such as SOS- or sporulation-inducing signals, resulting in the release of 
phage-like particles, which may kill other bacteria.138 Second, ribosomal proteins were 
also more abundant and diverse in sporulating EVs than vegetative EVs. In addition to 
structuring ribosome, ribosomal proteins may function in other diverse processes such 
as improving antibiotic resistance, integrating translation with other cellular pathways, 
and responding to stress.139 EVs may carry the ribosomal proteins to support the spore 
formation or to respond to environmental stressors. Another unexpected protein group 




mobility, responding to numerous attractants or repellents.140 They may be suggested 
to participate in sporulation by responding to nutrient depletion.  
3.4  Summary 
In the results of protein identifications obtained by proteomic methods, the total 
numbers of EV proteins identified and the numbers of unique peptides were 
comparable between vegetative EVs and sporulating EVs with more than 70% shared 
proteins. The distributions for the subcellular locations and the molecular functions of 
proteins were also similar between them. In the comparison of spectral counts, 
however, the relative abundance of each protein changed markedly, indicating the 
components in EVs are affected by growth stages of parental cells. This observation 
supports the general hypothesis that the shedding of EVs from cells is for distinct 
biological purposes. In particular, the EVs from sporulating cells contained 
significantly more proteins contributing directly and indirectly to spore formation. 
These proteins suggest that EVs may be a novel means for intercellular communication 
delivering sporulation-inducing proteins. In addition, proteins present, which respond 
to stresses and have antibiotic activity, were found in both EV types with higher 
abundances in sporulating EVs. These proteins showed possible functions of EVs in 




Chapter 4:   Observation of interaction between B. subtilis 
cells and EVs 
4.1  Introduction 
As a number of biologically functional components are carried by EVs from 
diverse organisms, it is proposed that EVs may participate in intercellular 
communications and host-pathogen interactions. Previous studies for internalizations 
of EVs or EV components into either eukaryotic or prokaryotic cells have supported 
this hypothesis.1,2,141,142 Endocytosis and membrane fusion are the two main pathways 
for internalization.76 The trafficking mechanism of EV components into bacterial cells 
is considered to be carried out by membrane fusion rather than endocytotic uptake, 
which is expected to occur only in eukaryotes. Although endocytosis-like uptake of 
proteins to bacterial cells has been reported, it is limited to the small number of bacterial 
species that show subcellular compartmentalization.143 The interaction of EVs from 
Gram-negative bacteria with both Gram-negative and -positive bacterial cells has been 
observed.15 However, the communication between Gram-positive bacterial EVs and 
their parental cells has not been studied. 
We and others have found that Gram-positive bacteria naturally shed EVs. In 
the previous chapter, B. subtilis EVs were shown to carry quantitatively different 
proteins, which have biological functions reflecting the two growth phases. This 




and assumption, an important unanswered question is how the contents in EVs can be 
delivered into bacterial cells in a population.  
 High-resolution microscopy and the use of fluorescence probes have emerged 
as powerful techniques to examine cell-to-cell, particle-to-cell, or particle-to-particle 
interactions. For example, TEM with thin-sectioning and gold particle labeling 
techniques have shown that the membrane fusion of EVs occurs at bacterial cell 
membranes and that the bacterial cells lyse because of the fusion.15  
Confocal microscopy is the most widely used method among various 
fluorescence microscopic techniques. In the study of EVs, relatively long-chains of 
lipophilic fluorescence dyes are often incorporated to overcome the limit of resolution 
for nano-scaled sizes. Using this technique, endocytotic uptake of EVs to eukaryotic 
cells and, rarely, membrane fusion have been observed.141,142,144 Deconvolution 
microscopy is considered to be a powerful alternative of confocal microscopy using 
computational algorithms, which remove blur of images.145,146 In general, this image 
processing is applied for wide-field microscope, but more recently, confocal 
micrographs have also been analyzed by deconvolution algorithms.145 Modern 
deconvolution techniques have showed resolution comparable to that from confocal 
microscopy. Deconvolution microscopy may be better for dim images of relatively 
small objects.  
In addition, assays optimized for membrane fusion using fluorescence probes 
are available such as NBD–rodamine energy transfer147 and octadecyl rhodamine B 
self-quenching.148 These methods allow successive and relatively accurate 




changes of fusion efficiency can also be estimated for EVs at varied environmental 
conditions.149 In this chapter, fluorescence microscopy with a deconvolution technique 
and fluorescence spectrophotometry were used to characterize the interaction between 
B. subtilis cells and their EVs. 
4.2  Materials and Methods 
4.2.1  Deconvolution fluorescence microscopy 
An aliquot of the sporulating EVs containing 100 µg of proteins was incubated 
with 5 µM DiD lipophilic dye for 15 min. Excess dye was removed by 
ultracentrifugation at 200,000 ×g for 90 min in 25 mL PBS. The pellet of DiD-bound 
EVs was resuspended in PBS. One colony of B. subtilis cells grown on BHI-agar plate 
was washed in PBS by centrifugation at 10,000 ×g for 3 min and suspended in PBS.  
The cells were incubated with the stained EVs for 0, 2, 5, 10, 20, 40, and 60 min. At 
each time point, 1/7 of the total volume was aliquoted and washed in PBS by 
centrifugation at 10,000 ×g for 3 min. The time point at 0 min indicates cells before the 
addition of stained EVs. The resulting pellets of incubated cells were then fixed in 4% 
paraformaldehyde for 10 min at room temperature and 50 min on ice.150 Lastly, the 
incubated cells were washed with PBS five times and mounted on slides with a final 
concentration of 1.5% low melting point agarose containing 0.5 µg/mL DAPI. All 
centrifugation steps were processed at 4 ̊C.  For dead cell-EV interaction test, the B. 
subtilis cells were pre-fixed with paraformaldehyde before the incubation with EVs. 




Olympus IX-71 inverted microscope linked to a DeltaVision deconvolution imaging 
system (Applied Precision, Issaquah, WA). Excitation filters of 390/18 and 632/22, and 
emission filters of 435/48 and 679/34 are used for DAPI and DiD, respectively. The 
fluorescence intensities of the cell membranes were determined using Image J 
software.83 
 
4.2.2  Membrane fusion assay  
The possibility of fusion between EVs and B. subtilis cells was tested using 
octadecyl rhodamine B chloride (R18, Hayward, CA), a self-quenching lipophilic 
dye.148,151 EVs isolated from sporulating B. subtilis cells, containing 25 µg of proteins 
were labeled with 30 µM ethanolic R18 probes in a staining buffer (50 mM Na2CO3 
and 130 mM NaCl, pH 8.5)144 at room temperature for 1 h. The R18-labeled EVs were 
washed with 200 mM NaCl in PBS twice by ultracentrifugation at 150,000 ×g for 70 
min. The final pellet of EVs was resuspended in the washing buffer. A single colony 
of B. subtilis cells grown in BHI agar were prepared by washing in PBS and pelleted 
at 10,000 ×g for 3 min. They were then resuspended in the washing buffer. The 
fluorescence of R18 labeled to EVs was measured continuously using the F-4500 
fluorescence spectrophotometer for 35 min with excitation at 560 nm and emission at 
590 nm with slits of 2.5 nm. The time scans were produced at room temperature with 
gentle shaking. After suspension of the EV for 5 min as an equilibration step, one-fifth 
of the prepared cells were added. The incubation was stopped by adding Triton X-100 
at a final concentration of 0.3%, resulting in the maximum of R18 fluorescence. The 




fluorescence de-quenching (FD) according to an equation  %FD = [(F-Fi)/(Fmax-
Fi)]× 100, where F indicates the fluorescence intensity at each time point, Fi is initial 
fluorescence of R18-labeled EVs before the injection of cells, and Fmax represents the 
maximal intensity after the injection of Triton X-100.  
4.3  Results and discussion 
All possible interaction pathways between EV and bacterium should be 
considered. Fluorescence microscopy was initially chosen to examine the unknown 
interactions. Specifically, a long-chain lipophilic dye and wide-field fluorescence 
microscope with Deltavision deconvolution software were used to visualize nano-
scaled EVs. In the test of dyes, DiD-labeled and DiO-labeled EVs were successfully 
detected on a Deltavision deconvolution microscope (Figure 15).  
Subsequently, DiD-stained EVs were incubated with live and dead (pre-fixed) 
B. subtilis cells separately (Figure 16). Internalization of intact EVs by endocytosis-
A B 
Figure 15. Deconvolution fluorescence microscopic images of EVs. B. subtilis EVs 




like uptake may result in intense DiD fluorescence as clear dots inside the cells, while 


























Figure 16. Deconvolution fluorescence images. (A) DAPI-stained B. subtilis cells (0 
min incubation), (B-C) Cells incubated with DiD labeled EVs for (B) 3 min, (C) 60 
min (representative images from 100-200 cells per time). DAPI labeled to 
chromosomes is in blue and DiD initially labeled to EVs is in red. (D) Normalized DiD 
fluorescence intensity on cell membranes over incubation time (Each single dot 
represents an average of >30 cell membranes). Intensities were measured with Image 






Endocytotic uptake was not seen. Instead, the red fluorescence signal on cell 
membrane was slightly enhanced as incubation time increased, suggesting fusion of the 
EVs into cell membrane (Figure 16). Also, the increase of red fluorescence intensity is 
higher in live cell incubation relative to dead cell incubation (Figure 16D). However, 
the overall increase of red fluorescence intensity was not strong and variability was 
broad across multiple cells. If fusion is occurring between cells and EVs, these results 
could be due to the fast dynamics of the fusion events and substantial dilution of DiD 
dye.2 Therefore, their interaction may be difficult to be visualized and quantified by 
fluorescence microscopy. 
Next, the fusion event between EVs and the cells was tested using fluorescence 
de-quenching measurement of the lipophilic probe R18. The R18 dyes are expected to 
be de-quenched by dilution of the probes resulting from lipid mixing. Their 
fluorescence would subsequently increase. The EVs were labeled with R18 and 
unlabeled B. subtilis cells were added after 5 min. The injection of B. subtilis cells 
induced a strong increase of the R18 fluorescence, suggesting that membrane fusion-
like events occurred between EVs and cells (Figure 17).   
As discussed previously, EVs would have difficulty contacting the Gram-
positive bacterial cell membrane because of the peptidoglycan layer on outmost cell 
surface. In the proteomic results from the previous chapter, cell wall hydrolytic 
enzymes were identified in EVs from both vegetative and sporulating cells 
(peptidoglycan DL-endopeptidase CwlO and N-acetylmuramoyl-L-alanine amidase 
LytC) (Appendix 1).  These autolysins in EVs may disrupt the peptidoglycan layer on 





4.4  Summary 
In this chapter, the question was asked whether the EVs can transfer their 
components to parental cells.  Interactions between them was sought by fluorescence 
microscopy and spectrophotometry with fluorescence probes. Deconvolution 
fluorescence microscopy opened the possibility of the communication. R18 
fluorescence quenching assay provided a definitive observation of the membrane 
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Figure 17. Fluorescence spectrophotometric detection of membrane fusion-like 
interaction between EVs and B. subtilis cells. (A) Fluorescence intensities of R18-
labeled EVs (sporulating) following addition of cells, and subsequent disruption with 





Chapter 5:   Conclusions and perspectives  
Two distinctive biological processes, the biogenesis of EVs and formation of 
spores were studied together in this thesis.  Although studies of Gram-positive bacterial 
EVs were initiated several decades ago, little is known about their biological function. 
At the start of this research, three major questions were addressed: (1) do B. subtilis 
cells shed EVs during sporulation?; (2) is the proteome of EVs different based on the 
growth phase?; (3) do the released EVs interact with parental B. subtilis cells? 
In regard to the first question, EVs were collected from sporulating cells in 
amounts comparable to EVs from vegetative cells. This observation demonstrated that 
EV biogenesis by B. subtilis is an on-going process, which occurs during sporulation, 
as well as during vegetative growth. The cell growth conditions and EV isolation 
procedure were optimized using sequential ultracentrifugation with several filtering 
steps. TEM analysis showed that the two EV populations were distributed in a similar 
size range. The EV purification steps could be further optimized based on the purposes 
of analysis. Especially for therapeutic applications of EVs, methods for obtaining 
extremely high purity as well as precise evaluation are required. In addition, 
classification of bacterial EVs based on their sizes might be implemented, because 
functions and shedding mechanisms of eukaryotic EVs have been considered to differ 
depending on their sizes.2  
The second question was addressed in the third chapter on proteomic analysis. 
EVs from sporulating cells were shown to contain a quantitatively different proteome 




number of proteins. The proteins from sporulating EVs showed higher relevance to 
biological processes contributing to cellular differentiation, while proteins from 
vegetative EVs are mainly annotated for metabolic processes. More importantly, 
several proteins abundant in sporulating EVs are known to kill other bacterial species 
and others participate directly in sporulation. The results suggest that the proteins 
carried by B.subtilis EVs reflect the growth stages of parental cells and environmental 
stressors. These EV proteins are proposed to support developmental processes 
including sporulation and bacterial survival. MS-based proteomics analysis is generally 
composed of several steps including peptide / protein sample preparation, separation, 
MS analysis, protein identification / scoring, and quantification. Diverse methods at 
each step have been developed and they result in a number of combinations for an 
analysis. Multipronged approaches to study the EV proteome using different MS-based 
methods will enrich our knowledge of the EVs.  
Information about transfer pathways of EV contents to Gram-positive bacterial 
cells was needed to understand the roles of protein cargo in EVs. In chapter 4, we tested 
the most plausible mechanism, membrane fusion. The spectrophotometric fluorescence 
de-quenching experiment showed a fusion-like event between EVs and cellular 
membranes of B. subtilis cells. This result supports the proposed function of EVs in 
intercellular communication. Considering the sporulation-associated proteins 
identified in EVs and the observed interaction between EVs and B. subtilis cells 
together, it may be assumed that EVs from sporulating bacteria promote further spore 




The studies presented in this thesis are expected to broaden the understanding 
of Gram-positive bacterial EVs and their relationship with sporulation. Additionally, 
these observations open further questions such as: (1) are the proteins in EVs 
biologically active?; (2) how do EVs affect the sporulation process?; (3) could the B. 
subtilis EVs interrupt growth of other bacteria?  Based on the present work, future 
biological research addressing these questions will support applications of the EVs shed 






Appendix table 1. Proteins identified in vegetative EVs and sporulating EVs (distinct peptides ≥2, PSM FDR < 5%, FDR-corrected p-
value ≤0.05) 























Q04789 36 76.67 7.52E-10 2 4.74 5.46E-67 -6.00 1.66E-44 Acetolactate synthase 
P94521 24 75.35 3.71E-10 2 5.81 1.22E-49 -5.25 4.94E-34 
Putative 
aminopeptidase YsdC 
P39751 16 51.65 5.84E-10 1 2.7 3.81E-14 -4.39 1.78E-10 MreB-like protein 





P19582 21 51.27 5.84E-10 1 4.16 2.17E-12 -4.22 2.53E-09 
Homoserine 
dehydrogenase 







O07603 20 54.34 6.35E-10 2 4.62 4.93E-25 -4.12 2.16E-18 
Putative 
aminopeptidase YhfE 




P26900 21 64.44 6.41E-10 4 2.04 2.07E-34 -3.85 1.68E-25 L-asparaginase 1 
P80879 13 68.97 6.59E-10 13 71.72 1.21E-14 -3.71 2.72E-11 
General stress protein 
20U 
P40924 8 52.79 2.74E-08 1 2.03 2.67E-08 -3.63 2.58E-06 
Phosphoglycerate 
kinase 
P45694 9 47.68 7.24E-10 2 3.45 2.79E-10 -3.57 3.91E-08 Transketolase 
P28598 102 92.65 7.95E-10 2 2.94 0.00E+00* -3.45 1.28E-247 60 kDa chaperonin 
O32106 11 58.8 4.16E-07 1 5.2 4.15E-07 -3.43 1.58E-05 
Probable cytosol 
aminopeptidase 
P05653 17 50.3 2.24E-10 5 7.43 5.92E-23 -3.39 1.05E-17 DNA gyrase subunit A 
P42974 12 54.22 9.20E-07 1 1.77 9.19E-07 -3.36 2.67E-05 NADH dehydrogenase 









Q02112 5 55.88 6.50E-06 1 1.57 6.50E-06 -3.18 1.01E-04 
Membrane-bound 
protein LytA 
P55910 9 52.5 1.82E-09 2 13.49 1.36E-09 -2.96 1.24E-07 L-lactate permease 
P26901 24 40.79 6.49E-05 1 1.66 6.49E-05 -2.94 4.81E-04 Vegetative catalase 
















P94356 27 87.78 6.57E-10 15 47.78 8.31E-36 -2.65 6.94E-29 
Uncharacterized 
protein YxkC 
P96499 19 35.04 8.90E-04 1 3.07 8.90E-04 -2.58 3.25E-03 
Putative transcriptional 
regulator YvhJ 





P54326 8 49.82 1.88E-03 1 7.14 1.88E-03 -2.47 5.56E-03 
Phage-like element 
PBSX protein XkdF 
P13243 20 70.88 4.59E-07 2 5.96 4.59E-07 -2.46 7.36E-06 
Probable fructose-
bisphosphate aldolase 
P39594 2 10.36 8.94E-08 2 11.7 8.90E-08 -2.43 2.01E-06 
Thiamine-phosphate 
synthase 
P19669 26 81.6 2.47E-07 1 3.77 2.47E-07 -2.37 4.20E-06 Transaldolase 
O34594 9 71.43 9.72E-06 1 7.25 9.72E-06 -2.24 7.22E-05 Cytochrome c-551 
P12425 65 85.14 6.59E-10 27 71.85 0.00E+00* -2.15 2.50E-246 Glutamine synthetase 
P40409 10 30.91 1.38E-04 2 3.15 1.38E-04 -2.14 5.66E-04 
Iron-uptake system-
binding protein 
P21880 98 89.57 3.71E-10 77 36.8 0.00E+00* -2.08 0.00E+00* 
Dihydrolipoyl 
dehydrogenase 






O32218 23 67.12 2.76E-08 17 59.01 2.68E-08 -2.02 4.58E-07 
Disulfide bond 
formation protein D 
O34385 9 63.4 5.81E-06 1 2.61 5.81E-06 -1.98 3.87E-05 
Manganese-binding 
lipoprotein MntA 
O32167 20 79.56 2.73E-09 4 13.14 2.35E-09 -1.97 5.35E-08 
Methionine-binding 
lipoprotein MetQ 
P13242 8 41.12 9.76E-03 3 9.16 9.76E-03 -1.72 1.73E-02 CTP synthase 




P39793 35 57.77 5.93E-10 11 27.5 3.27E-13 -1.68 7.74E-12 
Penicillin-binding 
protein 1A/1B 
O34633 18 94.29 7.52E-10 12 75 5.34E-27 -1.62 7.86E-24 
Uncharacterized 
protein YjlC 
P37580 9 36.83 3.66E-10 1 6.98 2.24E-12 -1.61 3.64E-11 
Iron(3+)-hydroxamate-
binding protein FhuD 
P54531 14 58.79 2.03E-06 1 2.75 2.03E-06 -1.58 1.17E-05 
Leucine 
dehydrogenase 
P37527 20 67.35 4.23E-08 5 23.47 4.19E-08 -1.49 3.82E-07 
Pyridoxal biosynthesis 
lyase PdxS 























P94541 19 49.2 2.77E-05 2 9.9 2.77E-05 -1.20 9.24E-05 Ribonuclease HIII 
P50849 20 50.5 1.64E-04 4 6.52 1.64E-04 -1.11 4.30E-04 
Polyribonucleotide 
nucleotidyltransferase 
P13714 40 80.31 9.57E-03 34 77.5 9.57E-03 -0.90 1.65E-02 
L-lactate 
dehydrogenase 
P54423 85 63.87 3.52E-09 23 49.11 2.74E-09 -0.38 1.40E-08 
Cell wall-associated 
protease 
P40767 5 12.9 5.12E-01 5 13.32 5.12E-01 -0.18 4.90E-02 
Peptidoglycan DL-
endopeptidase CwlO 




O34788 13 65.9 6.50E-06 8 17.05 6.50E-06 0.72 7.09E-06 
(R,R)-butanediol 
dehydrogenase 
P94431 3 22.55 9.49E-03 10 35.78 9.49E-03 0.78 1.16E-02 
Uncharacterized 
protein YcnI 
P54331 1 1.72 7.87E-04 5 13.52 7.87E-04 0.85 8.61E-04 
Phage-like element 
PBSX protein XkdK 















Q08352 11 51.32 1.13E-04 27 72.49 1.13E-04 1.27 9.14E-05 
Alanine 
dehydrogenase 




Q45493 33 80.18 4.76E-29 23 67.75 8.88E-10 1.42 1.18E-30 Ribonuclease J1 
Q02114 1 4.64 3.72E-01 2 4.84 3.72E-01 1.44 3.33E-02 
N-acetylmuramoyl-L-
alanine amidase LytC 
P42971 26 59.58 3.53E-26 7 3.74 8.17E-10 1.60 9.13E-28 
Penicillin-binding 
protein 3 
P42297 3 15.54 4.94E-04 4 22.97 4.94E-04 1.62 3.45E-04 
Universal stress 
protein YxiE 
P54608 5 7.6 2.67E-02 3 3.51 2.67E-02 1.66 2.21E-02 Hydrolase YhcX 
P20282 2 12.4 4.98E-02 6 42.98 4.98E-02 1.72 4.25E-02 
30S ribosomal protein 
S13 




O32052 2 21.35 2.74E-02 4 64.04 2.74E-02 1.75 2.20E-02 
UPF0092 membrane 
protein YrbF 
P32399 5 7.35 1.26E-08 3 3.23 1.30E-08 1.83 4.54E-09 
Uncharacterized 
protein YhgE 




P17820 3 7.34 3.80E-03 4 9 3.80E-03 1.98 2.57E-03 
Chaperone protein 
DnaK 












P42175 20 60.1 2.95E-41 17 54.15 5.41E-10 2.13 9.12E-44 
Nitrate reductase alpha 
chain 
P40403 2 23.44 1.18E-45 3 27.75 8.17E-10 2.17 2.11E-48 
CheY-P phosphatase 
CheC 
P34957 10 32.4 9.46E-26 5 9.35 7.73E-10 2.18 2.02E-27 
Quinol oxidase subunit 
2 
P42176 10 25.05 1.28E-26 8 14.78 7.88E-10 2.19 2.40E-28 
Nitrate reductase beta 
chain 




Q07833 2 1.33 2.03E-06 6 5.1 2.03E-06 2.33 8.96E-07 tRNA nuclease WapA 
O34790 1 7.02 4.46E-02 8 45.18 4.46E-02 2.38 2.80E-02 
Heptaprenylglyceryl 
phosphate synthase 





P0CI78 2 16.5 4.46E-02 6 40.78 4.46E-02 2.38 2.80E-02 
50S ribosomal protein 
L24 
P39606 2 6.01 1.16E-02 2 6.01 1.16E-02 2.41 6.75E-03 
Uncharacterized 
protein YwcH 












P50727 1 15.85 5.58E-04 8 48.78 5.58E-04 2.65 2.93E-04 Ferredoxin 




O34353 0 0 8.06E-02 8 25.57 8.06E-02 2.67 3.72E-02 
Uncharacterized 
protein YdjN 










P54459 0 0 8.06E-02 3 7.78 8.06E-02 2.67 3.72E-02 
Uncharacterized 
protein YqeN 
P54956 0 0 8.06E-02 12 30.79 8.06E-02 2.67 3.72E-02 
Uncharacterized 
protein YxeQ 
P70974 0 0 8.06E-02 2 12.41 8.06E-02 2.67 3.72E-02 
50S ribosomal protein 
L13 




P54341 6 14.08 5.20E-111 16 45.12 7.73E-10 2.68 2.19E-116 
Phage-like element 
PBSX protein XkdV 
P02394 2 19.51 9.02E-04 8 26.83 9.02E-04 2.82 4.73E-04 
50S ribosomal protein 
L7/L12 
P54375 2 13.86 1.97E-08 6 38.61 1.99E-08 2.87 7.01E-09 
Superoxide dismutase 
[Mn] 
P37809 37 61.95 1.08E-85 51 76.74 7.88E-10 2.88 1.25E-89 





P37808 27 53.78 4.08E-96 50 67.93 7.55E-10 2.97 3.36E-100 
ATP synthase subunit 
alpha 
O07543 0 0 3.16E-02 10 23.87 3.16E-02 2.98 1.47E-02 
UPF0754 membrane 
protein YheB 
O34645 0 0 3.16E-02 9 24.77 3.16E-02 2.98 1.47E-02 Alpha-galactosidase 








P51834 0 0 3.16E-02 3 3.12 3.16E-02 2.98 1.47E-02 
Chromosome partition 
protein Smc 




Q45585 0 0 3.16E-02 5 23.53 3.16E-02 2.98 1.47E-02 
ECF RNA polymerase 
sigma factor SigW 
O34841 1 7.18 1.63E-04 3 9.39 1.63E-04 3.04 8.26E-05 
Uncharacterized 
protein YoeB 
Q45584 1 4.64 1.40E-03 6 39.07 1.40E-03 3.09 6.95E-04 
Uncharacterized 
protein YbbK 




O05389 0 0 1.23E-02 2 4.99 1.23E-02 3.23 5.56E-03 
Uncharacterized 
oxidoreductase YrbE 
O07610 0 0 1.23E-02 2 4.29 1.23E-02 3.23 5.56E-03 
Long-chain-fatty-acid-
-CoA ligase 






P13267 0 0 1.23E-02 3 2.99 1.23E-02 3.23 5.56E-03 
DNA polymerase III 
PolC-type 
P54567 0 0 1.23E-02 6 19.67 1.23E-02 3.23 5.56E-03 
Uncharacterized 
protein YqkD 
P94367 0 0 1.23E-02 11 20.17 1.23E-02 3.23 5.56E-03 
ATP-binding/permease 
protein CydD 
P12875 1 7.38 5.63E-04 21 68.03 5.63E-04 3.23 2.87E-04 
50S ribosomal protein 
L14 
P42100 1 9.16 5.63E-04 2 11.78 5.63E-04 3.23 2.87E-04 Glycerate kinase 
P0CI74 7 55.1 1.07E-13 7 28.57 8.17E-10 3.29 2.05E-14 
Cell cycle protein 
GpsB 
O31529 2 3.32 1.11E-05 2 4.83 1.11E-05 3.31 5.56E-06 
Beta-galactosidase 
YesZ 
P54602 4 4.93 4.88E-75 19 67.38 9.95E-10 3.34 1.74E-77 Endonuclease YhcR 
O32023 3 27.27 2.23E-04 7 44.16 2.23E-04 3.35 1.13E-04 
Uncharacterized 
protein YqzC 
P96583 3 4.26 2.23E-04 2 3.3 2.23E-04 3.35 1.13E-04 DNA topoisomerase 3 
P80698 4 15.8 1.21E-15 8 18.87 6.04E-10 3.43 2.39E-16 Trigger factor 
P54334 4 5.48 1.98E-09 4 3.3 2.53E-09 3.43 8.01E-10 
Phage-like element 
PBSX protein XkdO 








O31760 14 48.83 9.63E-163 30 74.23 7.88E-10 3.54 3.66E-32 Ribonuclease J2 
O07021 1 4.18 7.47E-11 3 4.18 2.89E-10 3.61 2.24E-11 
Lactate utilization 
protein B 
O35000 0 0 1.66E-03 14 50.83 1.66E-03 3.63 8.16E-04 
Glucosamine-6-




P53001 1 2.8 1.32E-05 3 8.91 1.32E-05 3.67 7.30E-06 
Aspartate 
aminotransferase 




Q45597 3 6.55 1.45E-14 4 5.77 8.17E-10 3.76 4.34E-15 
Fructose-1,6-
bisphosphatase class 3 









O32072 0 0 6.06E-04 14 70.87 6.06E-04 3.79 3.23E-04 
Uncharacterized 
protein YtwF 
P37471 0 0 6.06E-04 7 44 6.06E-04 3.79 3.23E-04 
Cell division protein 
DivIC 
P54327 17 77.81 0.00E+00* 48 89.71 7.88E-10 3.93 0.00E+00* 
Phage-like element 
PBSX protein XkdG 




P54340 0 0 2.23E-04 12 35.94 2.23E-04 3.94 1.26E-04 
Phage-like element 
PBSX protein XkdU 
P17904 0 0 8.27E-05 8 52.5 8.27E-05 4.08 5.09E-05 
Serine-protein kinase 
RsbW 








P39456 0 0 2.95E-05 2 10.12 2.95E-05 4.20 1.97E-05 
L-cystine import ATP-
binding protein TcyC 
P54560 0 0 2.95E-05 3 5.83 2.95E-05 4.20 1.97E-05 DNA polymerase IV 2 
P55873 0 0 2.95E-05 10 54.62 2.95E-05 4.20 1.97E-05 
50S ribosomal protein 
L20 
P45921 5 25.4 1.17E-101 34 45.6 7.88E-10 4.21 1.12E-101 
Uncharacterized 
protein YqbE 
P21464 13 47.97 7.48E-195 43 77.64 7.55E-10 4.23 6.10E-194 
30S ribosomal protein 
S2 








O31740 0 0 1.84E-07 15 47.7 1.85E-07 4.69 1.87E-07 
Ribosome maturation 
factor RimM 
P54339 7 29.02 6.10E-122 16 54.6 9.95E-10 4.83 3.43E-119 
Phage-like element 
PBSX protein XkdT 
P94421 8 25.87 1.32E-41 22 40.69 7.55E-10 4.85 8.02E-41 
Uncharacterized ABC 
transporter solute-
binding protein YclQ 




P21467 0 0 2.46E-08 27 56.63 2.53E-08 4.85 2.90E-08 
30S ribosomal protein 
S5 







Q06796 0 0 9.03E-09 10 55.32 9.17E-09 4.92 1.16E-08 
50S ribosomal protein 
L11 
Q45596 0 0 9.03E-09 6 71.43 9.17E-09 4.92 1.16E-08 
Putative exported 
peptide YydF 
O32258 1 3.2 9.25E-16 4 4.94 7.88E-10 5.03 1.50E-15 
Uncharacterized 
glycosylase YvbX 
P46898 1 6.7 4.49E-17 17 62.57 7.88E-10 5.14 9.35E-17 
50S ribosomal protein 
L6 
P05657 0 0 2.14E-10 2 9.57 8.17E-10 5.18 2.78E-10 
50S ribosomal protein 
L27 
P21475 0 0 2.14E-10 5 30.38 8.17E-10 5.18 2.78E-10 
30S ribosomal protein 
S18 
P28628 0 0 7.71E-11 14 61.41 7.88E-10 5.24 1.11E-10 Signal peptidase I S 
P54332 3 20.41 7.76E-74 3 29.25 2.89E-10 5.28 3.38E-71 
Phage-like element 
PBSX protein XkdM 
P54507 0 0 2.78E-11 3 6.9 7.73E-10 5.30 4.37E-11 
Spore coat-associated 
protein N 




P04969 0 0 3.50E-12 6 37.4 8.17E-10 5.40 7.04E-12 
30S ribosomal protein 
S11 
Q45598 0 0 3.50E-12 3 3.24 8.17E-10 5.40 7.04E-12 
Uncharacterized 
protein YydD 




component of acetoin 
cleaving system 
P42060 0 0 1.90E-14 6 37.17 8.52E-10 5.64 6.28E-14 





P54325 4 27.68 7.72E-109 8 49.9 3.82E-10 5.65 1.35E-103 
Phage-like element 
PBSX protein XkdE 
P40406 0 0 1.08E-16 4 6.39 1.87E-10 5.84 5.87E-16 Beta-hexosaminidase 
P19946 0 0 2.49E-20 2 8.22 7.88E-10 6.12 3.36E-19 
50S ribosomal protein 
L15 
P12877 1 5.03 9.98E-42 16 50.84 7.88E-10 6.34 4.74E-39 
50S ribosomal protein 
L5 
P46899 0 0 2.49E-25 2 7.5 9.29E-11 6.42 1.12E-23 
50S ribosomal protein 
L18 




O31742 0 0 6.89E-35 7 46.96 4.37E-10 6.88 3.66E-32 
50S ribosomal protein 
L19 
P19405 1 1.95 6.81E-69 7 32.68 7.61E-10 7.04 2.34E-63 Alkaline phosphatase 3 
P21473 0 0 1.04E-46 7 41.57 3.33E-10 7.29 1.01E-42 
30S ribosomal protein 
S15 
P26908 0 0 2.10E-49 8 52.94 7.88E-10 7.37 3.95E-45 
50S ribosomal protein 
L21 
P42919 0 0 1.73E-59 3 8.66 7.73E-10 7.64 4.76E-54 
50S ribosomal protein 
L2 
P21469 0 0 2.59E-82 11 39.1 4.44E-10 8.10 2.38E-74 
30S ribosomal protein 
S7 
P21466 4 22 2.22E-193 20 65 7.55E-10 8.50 7.48E-174 
30S ribosomal protein 
S4 
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